African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2285

Full Length Research Paper

Biotransformation of coumarins by Cunninghamella elegans

Ghadai A. Attia
  • Ghadai A. Attia
  • Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 8130, Egypt.
  • Google Scholar
Kamillia A. Abou-El-Seoud
  • Kamillia A. Abou-El-Seoud
  • Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 8130, Egypt.
  • Google Scholar
Abdel-Rahim S. Ibrahim
  • Abdel-Rahim S. Ibrahim
  • Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 8130, Egypt.
  • Google Scholar


  •  Received: 27 July 2015
  •  Accepted: 22 October 2015
  •  Published: 15 May 2016

References

Beier RC, Nigg HN (1994). Toxicity of naturally occurring chemicals in food. Disease Handbook, Diseasescaused by hazardous substances. Eds.: Hui YH, Gorham JR, Murrell KD, Cliver DO, New York, pp: Marcel Dekker, New York: Marcel Dekker 3:1-186.

 

Beier RC, Oerti EH (1983). Psoralen and other linear furanocoumarins asphytoalexins in celary. Phytochemistry 22:2595–2597.
Crossref

 
 

Berenbaum MR (1991). Coumarins in herbivores. Their Interactions with secondary plant metabolites. Eds. Rosenthal G, Berenbaum MR. New York 37:163-179.

 
 

Dean FM (1963). Naturally occurring oxygen ring compounds, 1sted. London, Butter worth.

 
 

Dhalwa Kl, Shinde VM, Namdeo AG, Mahadik KR (2008). Antioxidant profile and HPTLC-densitometric analysis of umbelliferone and psoralen in Aeglemarmelos. Pharm. Biol. 46(4):266- 272.
Crossref

 
 

EL-Askary HI, Abou-Hussein DR, Gadelrab LN, Nassar NN (2008). Phytochemical and biological investigation of the ethyl acetate fraction of Cymbopogon Proximus Stapf. (Halfabar) herb. Egypt. J. Biomed. Sci. 26:149-157.

 
 

Feuer G, Kellen JA, Kovacs K (1976). Suppression of 7,12-dimethylbenz(α) anthracene-induced breast carcinoma by coumarin intherat. Oncology 33:35-39.
Crossref

 
 

Gebauer M (2007). Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg. Med. Chem. 15(6):2414-2420.
Crossref

 
 

Jamal S, Casley Smith JR (1989). The effects of 5,6 benzo-[a]-pyrone (coumarin) and DEC on filariticlymphoedema and elephantiasis in India. Preliminary results. India Ann. Trop. Med. Parasitol. 83:287-290.

 
 

Kumari GN, Ganesh MR, Anitha R, Aravind S (2004). Complete reduction of 2H-pyran-2-one moiety of coumarin and 6-methyl coumarin by Colletotrichumcapsici. Z. Naturforsch C 59(5-6):405-407.

 
 

Kalinowska M, Swislocka R, Lewandowski W (2007). The spectroscopic (FT-IR, FT-Raman and 1H, 13C NMR) and theoretical studies of cinnamic acid and alkali metal cinnamates. Mol. Struct. 834:572-580.
Crossref

 
 

Lake BG (1999). Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem. Toxicol. 37:423-453.
Crossref

 
 

Maucher A, Von Angerar E (1994). Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a ]anthracene-induced rat mammary carcinomas. Cancer Res. Clin. Oncol. 120(8):502-504.
Crossref

 
 

Musajo L, Rodighiero G (1962). The skin photosensitizing furocoumarins. Expreientia 18:153-161.
Crossref

 
 

Murray RDH, Mendez J, Brown SA (1982). The natural coumarins occurrence, chemistry and biochemistry. Eds.: Chichester, John Wiley & Sons. Bristol. pp. 67-92.

 
 

Myers RB, Parker M, Grizzle WE (1994). The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines. J. Cancer Res. Clin. Oncol. 120 (Suppl. No.1):S11-S13. Perel`son ME, Sheinker Y, Syrova GP, Turchin KF (1970). NMR spectra of natural coumarin derivatives. Khimiya Prirodnykh Soedinenii 6(1):6-14.

 
 

Pisklak M, Maciejewska D, Herold F, WawerI (2003). Solid state structure of coumarin anticoagulants: warfarin and sintrom.13C CPMAS NMR and GIAO DFT calculations. Mol. Struture 649:169-176.
Crossref

 
 

Rizzo JD, Davis PJ (1989). Microbial models of mammalian metabolism: Conversion of warfarin to 4′-hydroxywarfarin using Cunninghamellabainieri. Pharm. Sci. 78:183-189.
Crossref

 
 

Smith RV, Rosazza JP (1975). Microbial model of mammalin metabolism. J. Pharm. Sci. 64:1737-1759.
Crossref

 
 

Scott BR, Pathak MA, Mohn GR (1976). Molecular and genetic basis of furocoumarin reactions. Mutat. Res. 39:29-74.
Crossref

 
 

Sothers JB (1972). Carbon-13 NMR Spectroscopy, Eds. Blomquist and Wasserman, Academic Press, New York and Londo.

 
 

Shimada T, Yamazaki H, Guengerich FP (1996). Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations. Xenobio. 26:395-403.
Crossref

 
 

Steck W, Bailey BK (1969), Characterization of plant coumarins by combined gas chromatography,ultraviolet absorption spectroscopy, and nuclear magnetic resonance analysis1. Can. J. Chem. 47(19):3577-3383.
Crossref

 
 

Siegers CP, Bostelmann HC (1993). Effect of coumarin on cell cycle proliferationin human tumor cell lines. Irish Coll. Phys. Surg. 22:47-50.

 
 

Thornes D, Daly I, Lynch G (1989). Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Grou{p}. Eur. J. Surg. Oncol. 15(5):431-435.

 
 

Trumble JT, Dercks W, Quiros CF, Beier RC (1990). Host plant resistance and linear furanocoumarincontent of Apium accessions. J. Econ. Entomol. 83:519-525.
Crossref

 
 

Traven VF, Negrebetksy VV, Vorobjeva LI (1997). Keto-Enol tautomerism, NMR Spectra, and HD Exchange of 4- Hydroxycoumarins. Can. J. Chem. 75(4):377-383.
Crossref

 
 

Van Scott EJ (1976). Therapy of psoriasis. J. Am. Med. Assoc. 235:197-198.
Crossref

 
 

Wackett LP, Hershberger CD (1995). Biocatalysis and biodegradation microbial transformation of organic compounds. Eds.: Marcel Dekker, Inc., New York, USA. pp. 22-24.